Generic medicine

Magnesium Sulphate 50% Injection Injection

Reviewed educational reference: what Magnesium Sulphate is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.

Reviewed by Sohan Lal Kushwaha
Molecule
Magnesium Sulphate
Strength
50% Injection
Dosage form
Injection
Drug class
Electrolyte

Related products

No reviewed products are currently published for this generic.

Magnesium Sulphate 50% Injection Injection is a concentrated solution of Magnesium Sulphate, an essential mineral that acts as both an electrolyte replacement and a potent anticonvulsant. In clinical settings, it is most widely recognized for its use in the management of severe pre-eclampsia and eclampsia. It helps in preventing the onset of seizures and treating existing convulsions in pregnant women. Beyond obstetrics, it is used to treat severe hypomagnesemia and certain cardiac arrhythmias, such as Torsades de Pointes. Because of its narrow therapeutic window, Magnesium Sulphate 50% Injection Injection requires careful administration and constant monitoring of the patient to avoid toxicity.

At a glance

Quick look

Magnesium Sulphate 50% Injection Injection is a concentrated injection of Magnesium Sulphate.

How it works

It acts as an anticonvulsant and an electrolyte replacement.

Who it is for

It is the primary treatment for preventing seizures in eclampsia.

Uses it for
EclampsiaPre-eclampsiaHypomagnesemiaTorsades de PointesSevere AsthmaFetal Neuroprotection

Uses of Magnesium Sulphate

  • Prevention and treatment of seizures in eclampsia
  • Management of severe pre-eclampsia to reduce seizure risk
  • Correction of severe hypomagnesemia (low magnesium levels)
  • Treatment of Torsades de Pointes, a specific type of ventricular tachycardia
  • Management of severe acute asthma when other therapies fail
  • Neuroprotection for the fetus in cases of imminent preterm birth

Benefits of Magnesium Sulphate

Seizure Prophylaxis: Magnesium Sulphate 50% Injection Injection is the gold standard for preventing eclamptic seizures. It is more effective than other anticonvulsants like diazepam in reducing the risk of recurrence and improving maternal outcomes.

Cardiac Stabilization: In the case of Torsades de Pointes, Magnesium Sulphate helps stabilize the cardiac membrane, which reduces the risk of lethal arrhythmias and helps restore a normal heart rhythm.

Electrolyte Balance: It rapidly corrects severe magnesium deficits, which is essential for proper muscle function, nerve transmission, and enzymatic reactions in the body.

Side effects of Magnesium Sulphate

Common side effects of Magnesium Sulphate 50% Injection Injection include a feeling of warmth or flushing, sweating, and nausea. These often occur during the initial loading dose. More serious effects include hypotension, where blood pressure drops significantly, and muscle weakness. In cases of toxicity, patients may experience a loss of deep tendon reflexes, specifically the patellar reflex. Severe toxicity can lead to respiratory depression, where breathing becomes slow or shallow, and in extreme cases, cardiac arrest. These effects are usually dose dependent and can be reversed with the administration of calcium gluconate.

Side effectHow commonHow severeWhat to do
Flushing and SweatingCommonMildSlow the rate of infusion.
HypotensionCommonModerateDilute the drug and infuse slowly.
Respiratory DepressionRareSevereStop the infusion immediately.

How to manage side effects

Flushing and Sweating

  • Inform the patient it is normal
  • Monitor vitals
  • Continue infusion slowly

Hypotension

  • Check blood pressure
  • Adjust infusion rate
  • Administer fluids if needed

Respiratory Depression

  • Administer oxygen
  • Give Calcium Gluconate IV
  • Provide mechanical ventilation if needed

How to use Magnesium Sulphate

  • The 50% solution must be diluted before administration to avoid tissue damage and severe hypotension.
  • A loading dose is typically given slowly via intravenous infusion over 15 to 20 minutes.
  • A maintenance dose is then administered as a continuous infusion to keep serum magnesium levels within the therapeutic range.
  • Urine output must be monitored closely, as the drug is excreted by the kidneys.
  • The patellar reflex and respiratory rate must be checked every hour during treatment.

Special population advice

Kidney impairment

  • Reduce maintenance dose by 50% if creatinine clearance is low.
  • Monitor serum magnesium levels every 6 hours.

Liver impairment

  • No dose adjustment required as the drug is renally excreted.

Children

  • Use weight based dosing, typically 25 to 30 mg/kg for loading.
  • Monitor respiratory rate and reflexes every hour.

Elderly

  • Start with lower doses due to age related decline in GFR.
  • Frequent monitoring of urine output is essential.

How Magnesium Sulphate works

Magnesium Sulphate works by blocking the N-methyl-D-aspartate (NMDA) receptors in the brain, which reduces neuronal excitability and prevents seizures. It also acts as a calcium channel blocker, which helps in relaxing smooth muscles and stabilizing the cardiac membrane. By inhibiting the release of acetylcholine at the neuromuscular junction, it reduces muscle contractions.

What if you miss or exceed a dose?

If you miss a dose

Since Magnesium Sulphate 50% Injection Injection is administered as an injection in a hospital setting, a missed dose is usually a result of a pump failure or administration error. The healthcare provider should notify the physician immediately and restart the infusion as soon as possible to maintain therapeutic levels.

In case of overdose

Overdose of Magnesium Sulphate leads to hypermagnesemia. Early signs include loss of deep tendon reflexes and drowsiness. As levels rise, respiratory depression and hypotension occur. The most severe stage is cardiac arrest. The immediate treatment for overdose is the administration of intravenous calcium gluconate, which antagonizes the effects of magnesium.

AntidoteCalcium Gluconate

Administer 10 ml of 10% Calcium Gluconate IV slowly over 5 to 10 minutes.

Loss of Reflexes
The first sign of toxicity is the disappearance of the patellar reflex.
Respiratory Depression
Occurs as magnesium levels exceed 10 mEq/L, causing muscle paralysis.
Cardiac Arrest
Occurs at very high levels, usually above 25 mEq/L, due to cardiac membrane instability.
Renal Clearance
Forcing diuresis may help in some cases, but dialysis is the definitive treatment for severe toxicity.

Safety and precautions

When to avoid Magnesium Sulphate

Do not take if you
  • Severe Renal Failure

    eGFR below 30 ml/min increases toxicity risk significantly.

  • Myasthenia Gravis

    Can worsen muscle weakness and cause respiratory failure.

  • Heart Block

    May worsen conduction delays and lead to cardiac arrest.

Use with caution
  • Cardiac Arrhythmias

    Monitor heart rate and rhythm closely during infusion.

  • Respiratory Distress

    May worsen respiratory depression in patients with COPD.

  • Elderly Patients

    Reduced renal clearance requires lower maintenance doses.

  • Hypocalcemia

    Magnesium can further lower calcium levels in the blood.

Safety at a glance

AlcoholUse with caution

Avoid alcohol as it can increase CNS depression and respiratory risk.

PregnancySafe

Used specifically to treat eclampsia, but must be monitored by a specialist.

BreastfeedingSafe

Magnesium is excreted in breast milk but is generally safe in therapeutic doses.

DrivingUse with caution

Do not drive if you feel drowsy or experience muscle weakness.

KidneyUnsafe

Avoid or use with extreme caution in severe renal failure due to risk of toxicity.

LiverSafe

No significant liver adjustments needed, but monitor overall health.

AllergyUse with caution

Check for hypersensitivity to magnesium salts before administration.

ChildrenUse with caution

Use weight based dosing and monitor closely for respiratory depression.

ElderlyUse with caution

Elderly patients often have reduced kidney function, requiring lower doses.

Interactions

With other medicines

Calcium Channel Blockers

Moderate

Changes the medicine’s effect

What can happen: Reduced efficacy of magnesium.

What to do: Monitor serum magnesium levels closely.

Neuromuscular Blockers

Major

Changes the medicine’s effect

What can happen: Potentiation of muscle paralysis.

What to do: Reduce dose of neuromuscular blocker.

Furosemide

Moderate

Changes how the medicine is processed

What can happen: Increased magnesium excretion.

What to do: Increase magnesium supplementation dose.

With food and drink

  • High Phosphate FoodsMinor

    Excessive phosphate may interfere with magnesium absorption if taken orally, though less relevant for IV.

  • Ethanol and AlcoholModerate

    Alcohol consumption increases renal magnesium excretion and can exacerbate central nervous system depression when combined with magnesium therapy.

If you have another condition

  • Chronic Kidney Disease

    Severely impairs excretion, leading to rapid accumulation and toxicity.

  • Myasthenia Gravis

    Increases the risk of neuromuscular blockade and respiratory failure.

  • Heart Block

    Can exacerbate conduction delays in the heart.

Effect on laboratory tests

  • Serum Magnesium

    Increased

    Direct result of the administration of Magnesium Sulphate.

  • Ionized Calcium

    Decreased

    High magnesium levels can displace calcium and lower its concentration.

Quick tips

  • Always check the patellar reflex before and during the infusion of Magnesium Sulphate 50% Injection Injection.
  • Ensure that the patient has an adequate urine output of at least 30 ml per hour to prevent toxicity.
  • Keep a vial of 10% calcium gluconate ready at the bedside as an antidote.
  • Slowly dilute the 50% concentrate to prevent vein irritation and sudden blood pressure drops.
  • Monitor the respiratory rate closely, especially in patients with existing lung disease.

Counselling points

  • Toxicity SignsImportant

    Tell your nurse or doctor immediately if you feel sudden muscle weakness or difficulty breathing.

  • Common SensationsGood to know

    You may feel a warm flushing sensation or sweating during the infusion, which is normal.

  • AdministrationOptional

    This medication is given through a vein and requires constant monitoring by the staff.

Monitoring during treatment

Before starting

  • Serum magnesium
  • Serum creatinine
  • Urine output
  • Deep tendon reflexes

During treatment

  • every 1 hour: Check patellar reflex and respiratory rate

What is being watched

  • Patellar reflex
  • Respiratory rate
  • Urine output
  • Serum magnesium levels

Pharmacokinetics

Absorption
Rapid and complete when administered intravenously.
Bioavailability
100% via IV route.
Protein binding
Minimal protein binding.
Volume of distribution
0.5 to 0.7 L/kg.
Half-life
12 to 24 hours in healthy adults, significantly prolonged in renal failure.
Metabolism
Not metabolized by the liver.
Excretion
Primarily excreted unchanged by the kidneys.
Onset / duration
Onset is immediate with IV administration, duration depends on renal clearance.

Fact box

Chemical class
Inorganic Salt
Habit forming
No
Therapeutic class
Anticonvulsant
Action class
NMDA Receptor Antagonist
Storage
Store Magnesium Sulphate 50% Injection Injection in a cool, dry place away from direct sunlight. Keep the ampoules tightly sealed and store at room temperature.
ATC code
V03CX02
Pregnancy category
B

More information

Clinical Selection and the Gold Standard

Magnesium Sulphate 50% Injection Injection is selected as the first line therapy for eclampsia based on extensive evidence from the Collaborative Eclampsia Trial. This study showed that Magnesium Sulphate is significantly more effective than diazepam or phenytoin in preventing the recurrence of seizures. Clinicians prefer it because it not only controls convulsions but also provides a degree of neuroprotection for the fetus. While other drugs might stop a seizure, they do not offer the same level of maternal and fetal safety. The choice of Magnesium Sulphate 50% Injection Injection is therefore based on its superior ability to reduce maternal mortality and morbidity in the context of hypertensive disorders of pregnancy.

Comparison with Antihypertensives

A common misconception is that Magnesium Sulphate 50% Injection Injection is used to treat high blood pressure in pre-eclampsia. While it may cause a slight drop in blood pressure, it is not an antihypertensive drug. For the actual management of severe hypertension, clinicians use drugs like Labetalol or Hydralazine. Magnesium Sulphate is used specifically for seizure prophylaxis. Using it as a substitute for blood pressure medication can be dangerous, as the blood pressure may remain dangerously high even while the patient is protected from seizures. Therefore, it is usually used in combination with antihypertensive agents rather than as a replacement.

The Importance of the Magnesium Triad

Safe administration of Magnesium Sulphate 50% Injection Injection depends on monitoring what is often called the magnesium triad. This consists of the patellar reflex, respiratory rate, and urine output. The patellar reflex is the most sensitive indicator of toxicity, disappearing before respiratory depression occurs. Urine output is critical because the kidneys are the only way the body removes Magnesium Sulphate. If the patient develops oliguria, the drug levels will rise rapidly, leading to toxicity. Respiratory rate is the final safety check, as magnesium can cause neuromuscular blockade. Monitoring these three parameters allows the clinician to adjust the dose before life threatening toxicity occurs.

Common Misconceptions in Practice

Many practitioners believe that any patient with pre-eclampsia needs Magnesium Sulphate 50% Injection Injection. However, it is typically reserved for severe pre-eclampsia or eclampsia. Using it in mild cases may expose the patient to unnecessary risks of toxicity without significant benefit. Another misconception is that the drug is safe for all pregnant women. In reality, those with renal impairment or myasthenia gravis are at high risk. It is also wrongly assumed that the loading dose is the most dangerous part. While the loading dose can cause flushing, the maintenance dose is where most toxicity occurs due to gradual accumulation in the blood over several days.

References

  1. Electronic Medicines Compendium. Magnesium Sulphate Injection, Summary of Product Characteristics.View sourceAccessed
  2. NAFDAC. Magnesium Sulphate Injection Summary of Product Characteristics.View sourceAccessed
  3. World Health Organization. Prequalification of Medicines, Magnesium Sulphate Injection.View sourceAccessed
  4. DailyMed, US National Library of Medicine. Magnesium Sulfate Injection label.View sourceAccessed
  5. NAFDAC. Magphate Magnesium Sulfate Injection SMPC.View sourceAccessed
  6. Goodman & Gilman's The Pharmacological Basis of Therapeutics.Accessed
  7. Katzung Basic and Clinical Pharmacology.Accessed

Frequently asked questions about Magnesium Sulphate

Is Magnesium Sulphate 50% Injection Injection used to lower blood pressure in pregnancy?

No, Magnesium Sulphate 50% Injection Injection is used to prevent seizures in eclampsia. It is not primarily an antihypertensive drug, although it may have a mild effect on blood pressure.

What happens if the patellar reflex is lost?

The loss of the patellar reflex is an early sign of magnesium toxicity. The infusion should be stopped immediately and the doctor notified.

Can Magnesium Sulphate 50% Injection Injection be given as a bolus?

The 50% concentrate should never be given as a rapid bolus. It must be diluted and infused slowly to avoid cardiac arrest or severe hypotension.

What is the antidote for magnesium overdose?

The antidote is calcium gluconate, usually given as a 10% solution intravenously over 5 to 10 minutes.

Why is urine output monitored during treatment?

Magnesium is excreted almost entirely by the kidneys. If urine output drops, the drug accumulates in the blood, leading to toxicity.

Latest